Higher Q2 profit invigorates Novartis India

News Flash

ACQUISITION TO BE INCREMENTALLY POSITIVE FOR RELIANCE INDUSTRIES
UNLIKELY TO SEE SHARP CORRECTION IN MARKETS, NOT POSITIVE ON REALTY SPACE
IMPORTS & EXPORTS TO BE USED TO KEEP SUGAR PRICES RANGE BOUND
NEED A LONGER TERM PRICE OBJECTIVE FOR CROPS LIKE SUGARCANE
RIL TO GET CHEAP FEEDSTOCK VIA LYONDELL BASELL ACQUISITION
RIL TO GET CHEAP FEEDSTOCK VIA LYONDELLBASELL ACQUISITION
RIL IN A MUCH STRONGER POSITION THAN COMPETITORS FOR THIS ACQUISITION
RIL WILL GET CHEAP FEEDSTOCK BY THIS ACQUISITION
MARKET DIVIDED OVER FED'S DIRECTION IN TERMS OF INTEREST RATES
INDIAN ECONOMY LOOKING A LOT BETTER THAN OTHERS
HANG SENG UP 0.56%; NIKKEI DOWN 0.54%; KOSPI DOWN 0.17%
ACQUISITION TO GIVE RIL BARGAINING POWER IN PROCUREMENT & SALES
JAPANESE MARKET SHUT TODAY ON ACCOUNT OF THANKS GIVING
RIL'S INTEREST DOESN'T COMMIT MUCH NOW BUT GETS RIL A FOOT IN THE DOOR
NYMEX CRUDE AT $78/BBL ON TENSIONS BETWEEN IRAN & WESTERN NATIONS
HDIL LOSES 1.5%, ADDS 9 LAKH SHARES IN OPEN INTEREST
NTPC GAINS 1.1%, ADDS 12.7 LAKH SHARES IN OPEN INTEREST
BHARTI LOSES 1.5%, ADDS 14.7 LAKH SHARES IN OPEN INTEREST
DENA BANK GAINS 13.7%, ADDS 45.9 LAKH SHARES IN OPEN INTEREST
NIFTY NOVEMBER FUTURES SHED 14.5 LAKH SHARES IN OPEN INTEREST
NIFTY PREMIUM OF 13.8 POINTS VS A DISCOUNT OF 2.4 POINTS ON THURSDAY
NIFTY ROLLOVERS STOOD AT 26.7%
NIFTY NOVEMBER PUT-CALL RATIO AT 1.83 VS 1.58 ON THURSDAY
FOREIGN FUNDS NET SELL RS.463.89 CR IN EQUITIES ON NOVEMBER 20 (PROV)
MUTUAL FUNDS NET SELL RS.176.7 CR IN EQUITIES ON NOVEMBER 19
DII'S NET BUY RS.18.46 CR IN EQUITIES ON NOVEMBER 20 (PROV)
TO ENTER INTO CUSTOMIZED MOTOR CYCLE BIZ VIA PRO-BIKING SHOWROOMS
TO EXPAND PANTNAGAR CAPACITY TO 70,000 UNITS IN NEXT FEW MONTHS
AKER IS A NORWEGIAN SERVICE PROVIDER CO FOR OIL AND GAS OPERATIONS
AKER SOLUTIONS TO PROVIDE SUPPORT SERVICES IN KG BASIN

Updated: 30/10/2009 | 12:00 AM IST

Hot pursuit

Capital Market

Friday, October 30, 2009 (New Delhi)

Blog

Comments:

Read (0)

Post

Rate the story

The company announced the results after market hours on Thursday, 29 October 2009.

Meanwhile, the BSE Sensex was up 212.85 points, or 1.33%, to 16,265.57.

On BSE, 271 shares were traded in the counter as against an average daily volume of 8,045 shares in the past one quarter.

The stock hit a high of Rs 544 and a low of Rs 531 so far during the day. The stock had hit a 52-week high of Rs 600 on 29 September 2009 and a 52-week low of Rs 225.10 on 2 December 2008.

Ahead of Q2 September 2009 results, the stock had declined 2.03% to Rs 528.65 on 29 October 2009.

The mid-cap stock had outperformed the market over the past one month till 29 October 2009, falling 2.30% as compared to the Sensex's 4.75% fall. It had also outperformed the market in the past one quarter, rising 22.73% as compared to the Sensex's return of 5.79%.

The company's equity capital is Rs 15.98 crore. Face value per share is Rs 5.

The current price of Rs 536.05 discounts the company's Q2 September 2009 annualized EPS of Rs 41.63, by a PE multiple of 12.88.

Novartis India's net sales rose 4.6% to Rs 161.54 crore in Q2 September 2009 over Q2 September 2008.

Novartis India is engaged in manufacturing and marketing drugs, pharmaceutical products and formulations for consumer healthcare and animal healthcare. The company operates in four segments: pharmaceuticals, generics, OTC and animal health.

Powered by Capital Market - Live News